COVID-19 registry for atopic dermatitis patients (SECURE-AD)
Have any of your patients with atopic dermatitis developed COVID-19?
Please report your cases to SECURE-AD via a simple anonymised case report form.
SECURE-AD is a global registry for healthcare professionals to report outcomes of COVID-19 in individuals with atopic dermatitis.
Entering your cases is quick and can be done during a virtual consultation. All data is de-identified.
The information you provide will rapidly improve our understanding of how factors such as systemic immunomodulatory therapies, comorbidities and disease activity affect outcomes of COVID-19 in atopic dermatitis. Regular open-access summaries of reported cases will be provided online.
We look forward to working with you all on this important international effort.
- Alan IRVINE, Phyllis SPULS, and Carsten FLOHR
on behalf of the SECURE-AD Steering Group
- Alain TAIEB and Andreas WOLLENBERG
on behalf of the SECURE-AD Scientific Advisory Committee